Russia plans to increase procurements of rare disease drugs

Russia plans to increase procurements of drugs against rare diseases despite the current tough business environment and maintaining sanctions pressure, reports The Pharma Letter’s local correspondent.

It is expected, that most of such procurements will be carried out on the basis of the existing local foundations, such as "Circle of Good" and some others.

As part of these plans, recently completed procurements of Vyjuvek (beremagen heperpavec)from USA-based Krystal Biotech (Nasdaq: KRYS), a drug against butterfly syndrome. According to some Russian media, the supplies of the drug throughout Russia have already begun.